Sabay, Maudina T.

HRN: 23-65-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
CEFTRIAXONE 1G (VIAL)
09/04/2023
09/10/2023
IV
2g
Od
Pleural Effusion, R
Checking Final Appropriateness 
09/06/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/06/2023
09/13/2023
IV
4.5g
Q8H
Cholecystitis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: